BRAVO GROUP

Lobbying Income

$4.5M

Filings

123

Unique Clients

Active Period

2005–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	$90,000	3	1
2025	$160,000	4	1
2024	$160,000	4	1
2023	$120,000	5	2
2022	$350,000	9	2
2021	$420,000	7	2
2020	$400,000	4	1
2019	$360,000	4	1
2018	$350,000	4	1
2017	$370,000	4	1
2016	$240,000	4	1
2015	$210,000	4	1
2014	$230,000	4	1
2013	$360,000	4	1
2012	$270,000	4	1
2011	$380,000	11	3
2010	—	11	3
2009	—	8	2
2008	—	8	2
2007	—	6	2
2006	$0	5	2
2005	$20,000	6	2

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	$4,140,000	64	2011–2026
WE WORK FOR HEALTH	$330,000	9	2021–2023
GEISINGER HEALTH SYSTEMS	$20,000	27	2005–2011
ACADEMY OF NATURAL SCIENCES	$0	20	2005–2011
FEDERAL HOME LOAN BANK OF PITTSBURGH	—	3	2010

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	70
SENATE	70

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	62
Budget/Appropriations	Budget/Appropriations	46
Health Issues	Health Issues	10
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	7
Medicare/Medicaid	Medicare/Medicaid	7
Banking	Banking	2
Clean Air and Water (quality)	Clean Air and Water (quality)	1
Environment/Superfund	Environment/Superfund	1

BRAVO GROUP — Lobbying Disclosure | Poliscope